Ivanna V. Bihun

766 total citations
6 papers, 130 citations indexed

About

Ivanna V. Bihun is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Ivanna V. Bihun has authored 6 papers receiving a total of 130 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pulmonary and Respiratory Medicine, 2 papers in Oncology and 1 paper in Surgery. Recurrent topics in Ivanna V. Bihun's work include Brain Metastases and Treatment (4 papers), Lung Cancer Research Studies (2 papers) and Wound Healing and Treatments (1 paper). Ivanna V. Bihun is often cited by papers focused on Brain Metastases and Treatment (4 papers), Lung Cancer Research Studies (2 papers) and Wound Healing and Treatments (1 paper). Ivanna V. Bihun collaborates with scholars based in United States, Japan and Germany. Ivanna V. Bihun's co-authors include Gerlinde R. Van de Walle, Rebecca M. Harman, Daniel P. Cahill, Priscilla K. Brastianos, Christopher Alvarez‐Breckenridge, Alexandria L. Fink, María Martínez-Lage, Matthew Lastrapes, Stephen Schmidt and Tristan Penson and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and Neurosurgery.

In The Last Decade

Ivanna V. Bihun

6 papers receiving 130 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ivanna V. Bihun United States 4 50 47 45 42 29 6 130
Brian M. Rapp United States 6 42 0.8× 27 0.6× 77 1.7× 35 0.8× 20 0.7× 8 163
Charissa Jessurun Netherlands 6 49 1.0× 57 1.2× 33 0.7× 92 2.2× 5 0.2× 11 169
Joo Yeon Nam United States 5 92 1.8× 39 0.8× 42 0.9× 20 0.5× 21 0.7× 7 156
Yun Jee Kang United States 6 41 0.8× 12 0.3× 37 0.8× 22 0.5× 20 0.7× 10 93
Jinping Liu China 5 68 1.4× 32 0.7× 50 1.1× 31 0.7× 6 0.2× 9 150
Vasco Pinto Portugal 4 13 0.3× 20 0.4× 54 1.2× 52 1.2× 39 1.3× 6 153
Joshua D’Rozario Australia 4 89 1.8× 25 0.5× 76 1.7× 23 0.5× 7 0.2× 5 197
Alia Shamikh Sweden 6 19 0.4× 19 0.4× 46 1.0× 18 0.4× 8 0.3× 9 114
Claire Blanchard‐Delaunay France 7 92 1.8× 31 0.7× 54 1.2× 19 0.5× 6 0.2× 10 197
Michael Devitt United States 6 63 1.3× 33 0.7× 43 1.0× 43 1.0× 6 0.2× 31 148

Countries citing papers authored by Ivanna V. Bihun

Since Specialization
Citations

This map shows the geographic impact of Ivanna V. Bihun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ivanna V. Bihun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ivanna V. Bihun more than expected).

Fields of papers citing papers by Ivanna V. Bihun

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ivanna V. Bihun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ivanna V. Bihun. The network helps show where Ivanna V. Bihun may publish in the future.

Co-authorship network of co-authors of Ivanna V. Bihun

This figure shows the co-authorship network connecting the top 25 collaborators of Ivanna V. Bihun. A scholar is included among the top collaborators of Ivanna V. Bihun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ivanna V. Bihun. Ivanna V. Bihun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
1.
Ippen, Franziska M., Christopher Alvarez‐Breckenridge, Benjamin M. Kuter, et al.. (2019). The Dual PI3K/mTOR Pathway Inhibitor GDC-0084 Achieves Antitumor Activity in PIK3CA -Mutant Breast Cancer Brain Metastases. Clinical Cancer Research. 25(11). 3374–3383. 61 indexed citations
2.
Fujio, Shingo, Tareq A. Juratli, Kazunori Arita, et al.. (2018). A Clinical Rule for Preoperative Prediction of BRAF Mutation Status in Craniopharyngiomas. Neurosurgery. 85(2). 204–210. 32 indexed citations
3.
Alvarez‐Breckenridge, Christopher, Sanjay M. Prakadan, Eudocia Q. Lee, et al.. (2018). CMET-20. EVIDENCE OF CNS RESPONSE OF PEMBROLIZUMAB FOR LEPTOMENINGEAL CARCINOMATOSIS AT A SINGLE CELL RESOLUTION. Neuro-Oncology. 20(suppl_6). vi57–vi58. 1 indexed citations
4.
Ippen, Franziska M., Christopher Alvarez‐Breckenridge, Benjamin M. Kuter, et al.. (2018). CSIG-29. THE DUAL PI3K/mTOR-PATHWAY INHIBITOR GDC-0084 ACHIEVES ANTITUMOR ACTIVITY IN BREAST CANCER BRAIN METASTASES IN VITRO AND IN VIVO. Neuro-Oncology. 20(suppl_6). vi49–vi49. 1 indexed citations
5.
Brastianos, Priscilla K., Sanjay M. Prakadan, Christopher Alvarez‐Breckenridge, et al.. (2018). Phase II study of pembrolizumab in leptomeningeal carcinomatosis.. Journal of Clinical Oncology. 36(15_suppl). 2007–2007. 17 indexed citations
6.
Harman, Rebecca M., Ivanna V. Bihun, & Gerlinde R. Van de Walle. (2017). Secreted factors from equine mesenchymal stromal cells diminish the effects of TGF‐β1 on equine dermal fibroblasts and alter the phenotype of dermal fibroblasts isolated from cutaneous fibroproliferative wounds. Wound Repair and Regeneration. 25(2). 234–247. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026